))
What to expect in the trial of ex-Theranos CEO Elizabeth Holmes
Manage episode 302999066 series 2893097
Conteúdo fornecido por Dean Fanelli and Dr. Dean Fanelli. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Dean Fanelli and Dr. Dean Fanelli ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
The highly anticipated trial of ex-Theranos CEO Elizabeth Holmes is underway in San Jose, California. The Stanford dropout who was once a Silicon Valley darling faces felony charges that she duped elite financial backers, customers and patients. Her startup, Theranos, promised to revolutionize the medical world by diagnosing diseases with just a few drops of blood — but the technology didn’t live up to expectations and may never have worked at all. What can we expect from the Theranos Trial?
My guest today is Attorney Tom Lallas. A trial lawyer for more than 42 years, Tom has represented and tried cases for institutional clients, entrepreneurs, real estate investors, commercial lenders, and tech companies and is probably best known for his win in the trial over copyright issues in the Stan Lee v. Marvel case. He frequently appears in the media to comment on and explain legal issues.
Other stories covered include:
COVID-19 and the U.S. courts: challenges to vaccine requirements https://www.reuters.com/legal/government/covid-19-us-courts-challenges-vaccine-requirements-2021-09-22/
Gottlieb says vaccines could be approved for kids 5-11 by end of October https://www.cbsnews.com/news/covid-19-vaccines-children-october-gottlieb-face-the-nation/
It may take 'many, many' more vaccine mandates to end the Covid-19 pandemic, Fauci says https://www.cnn.com/2021/09/13/health/us-coronavirus-monday/index.html
About Dr. Dean Fanelli Dean Fanelli, Ph.D. is a patent, regulatory, and transactional attorney in the Washington, DC office of Cooley LLP (www.cooley.com) focusing on issues related to the development, protection, and commercialization of biotech and pharmaceutical products. In addition to Dr. Fanelli's expertise relating to legal issues involved in pharma and biotech development, Dr. Fanelli also understands the business needs of his clients as he has co-founded three biotechnology companies: PhosImmune, Inc. an immuno-oncology company, C-Reveal Therapeutics, LLC, an immuno-oncology drug development company focused on exposing tumors to immune responses and therapies, and most recently AexeRNA Therapeutics, LLC, an mRNA company developing advanced Lipid Nanoparticle delivery systems that reduce the side effects present in currently authorized mRNA COVID-19 vaccines. He is a regular on TV & Radio commenting on Covid-19 & Vaccines & also hosts his own podcast “Politics & Life Sciences Radio.”
51 episódios
Compartilhar
